The DOI matches its Crossref record; 280 of the 280 references it cites were found in a registry or an index.
Heparin and Low-Molecular-Weight Heparin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–280 of 280
Holmer, E., Lindahl, U., Bäckström, G., Thunberg, L., Sandberg, H., Soderstrom, G. F., & Andersson, L.-O. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90208-x · Cited by 107
Venous thromboembolism prevention in gynecologic cancer surgery: A systematic review
Einstein, M. H., Pritts, E. A., & Hartenbach, E. M. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.03.004 · Cited by 107
Omri, A., Delaloye, J.-F., Andersen, H., & Bachmann, F. (1989) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646526 · Cited by 106
Hamulyák, K., Lensing, A. W. A., van der Meer, J., Smid, W. M., van Ooy, A., Hoek, J. A., & for the Fraxiparine Oral Anticoagulant Study Group (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649959 · Cited by 106
Ockelford, P., Carter, C. J., Mitchell, L. M., et al. (1982) · Thrombosis Research · doi:10.1016/0049-3848(82)90121-9 · Cited by 106
Blajchman, M. A., Young, E., & Ofosu, F. A. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb22507.x · Cited by 105
Heparin-Induced Spinal Fractures
Squires, J. W., & Pinch, L. W. (1979) · JAMA · doi:10.1001/jama.1979.03290480051024 · Cited by 102
Simonneau, G., Laporte, S., Mismetti, P., Derlon, A. B., Samii, K., Samama, C. M., & Bergman, J. F. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02083.x · Cited by 100
Ofosu, F. A., Hirsh, J., Esmon, C. T., Modi, G. J., Smith, L. M., Anvari, N., Buchanan, M. R., Fenton, J. W., & Blajchman, M. A. (1989) · Biochemical Journal · doi:10.1042/bj2570143 · Cited by 96
Self-citationHeparin therapy in venous thromboembolism
Wilson, J., BYNUM, L. J., & Parkey, R. W. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90537-4 · Cited by 96
Akl, E. A., van Doormaal, F. F., Barba, M., et al. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006652 · Cited by 95
EFFECTIVENESS OF LOW-DOSE HEPARIN IN PREVENTION OF MYOCARDIAL REINFARCTION
Serneri, G. G. N., Gensini, G., Carnovali, M., Rovelli, F., Pirelli, S., & Fortini, A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90291-1 · Cited by 93
Selective hypoaldosteronism after prolonged heparin administration
Wilson, I. D., & Goetz, F. C. (1964) · The American Journal of Medicine · doi:10.1016/0002-9343(64)90110-x · Cited by 91
Durham, J. R. (1993) · Journal of Vascular Surgery · doi:10.1016/0741-5214(93)90663-7 · Cited by 91
Shojania, A. M., Tetreault, J., & Turnbull, G. J. (1988) · American Journal of Clinical Pathology · doi:10.1093/ajcp/89.1.19 · Cited by 89
Andersson, G., Fagrell, B., HOLMGREN, K., Johnsson, H., Ljungberg, B., Nilsson, E., Wilhelmsson, S., & ZETTERQUIST, S. (1982) · Thrombosis Research · doi:10.1016/0049-3848(82)90001-9 · Cited by 88
Recurrent Venous Thrombosis and Heparin Therapy
Anand, S. S., Bates, S., Ginsberg, J. S., Levine, M., Buller, H. R., Prins, M. H., Haley, S., Kearon, C., Hirsh, J., & Gent, M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.17.2029 · Cited by 88
Self-citationKitchen, S., & Preston, F. E. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650358 · Cited by 88
Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty
Popma, J. J., Coller, B. S., Ohman, M. E., Bittl, J. A., Weitz, J. I., Kuntz, R. E., & Leon, M. B. (1995) · CHEST Journal · doi:10.1378/chest.108.4_supplement.486s · Cited by 87
Brayden, D. J., Creed, E., O’Connell, A. W., Leipold, H. R., Agarwal, R., & Leone‐Bay, A. (1997) · Pharmaceutical Research · doi:10.1023/a:1012192115828 · Cited by 86
Charbonnier, B., Fiessinger, J., Banga, J. D., Wenzel, E., d’Azemar, P., Sagnard, L., & FRAXODI group (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615089 · Cited by 86
Highly active heparin species with multiple binding sites for antithrombin
ROSENBERG, R. D., Jordan, R. E., Favreau, L. V., & Lam, L. H. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)90260-2 · Cited by 85
Monréal, M., Zacharski, L. R., Jiménez, J. A., Roncalés, J., & Vilaseca, B. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00853.x · Cited by 84
Faunø, P. Z., Suomalainen, O. T., Rehnberg, V., Hansen, T. B., Krøner, K., Soimakallio, S., & Nielsen, E. (1994) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199412000-00007 · Cited by 84
Contemporary Laboratory Monitoring of Low Molecular Weight Heparins
Samama, M. M., & Poller, L. (1995) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30347-0 · Cited by 83
Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction
Kaplan, K. J., Davison, R., Parker, M. A., Mayberry, B., Feiereisel, P., & Salinger, M. H. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90792-2 · Cited by 83
Intravenous nitroglycerin-induced heparin resistance: A qualitative antithrombin III abnormality
Becker, R. C., Corrao, J. M., Bovill, E. G., Gore, J. M., Baker, S. P., Miller, M. L., Lucas, F. V., & Alpert, J. (1990) · American Heart Journal · doi:10.1016/s0002-8703(05)80172-3 · Cited by 82
Pini, M., Pattacini, C., Quintavalla, R., Poli, T., Megha, A., Tagliaferri, A., Manotti, C., & Dettori, A. G. (1990) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1647289 · Cited by 82
Agnelli, G., Pascucci, C., Cosmi, B., & Nenci, G. G. (1990) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1645195 · Cited by 82
Mahaffey, K. W., Granger, C. B., Collins, R., O’Connor, C. M., Ohman, E. M., Bleich, S. D., Col, J. J., & Califf, R. M. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89305-8 · Cited by 81
Self-citationCharacterization of Unfractionated Heparin: Comparison of Materials from the last 50 Years
Gray, E., Barrowcliffe, T. W., & Mulloy, B. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614170 · Cited by 80
Audit of control of heparin treatment.
Fennerty, A. G., Thomas, P. S., Backhouse, G., Bentley, P. G., Campbell, I. A., & Routledge, P. (1985) · BMJ · doi:10.1136/bmj.290.6461.27-a · Cited by 75
Shaughnessy, S. G., Hirsh, J., Bhandari, M., Muir, J. M., Young, E., & Weitz, J. I. (1999) · Blood · doi:10.1182/blood.v93.4.1231 · Cited by 75
Self-citationHEPARIN DOSES AND MAJOR BLEEDINGS
Morabia, A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91421-2 · Cited by 74
Nicolaides, A. N., Cesarone, M. R., LAURORA, G., Sanctis, M. T. D., INCANDELA, L., Barsotti, A., Corsi, M., Vasdekis, S. N., Christopoulos, D., Lennox, A., et al. (1999) · Angiology · doi:10.1177/000331979905001001 · Cited by 73
Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism
Hirsh, J., Siragusa, S., Cosmi, B., & Ginsberg, J. S. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642702 · Cited by 71
Self-citationHurst, R. E., Poon, M., & GRIFFITH, M. J. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111028 · Cited by 67
Inhibition of Thrombin Induced Aggregation of Human Platelets by Heparin
Eika, C. (1971) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1971.tb01976.x · Cited by 67
A new regimen for heparin use in acute coronary syndromes
Hochman, J. S., Wali, A. U., Gavrila, D., Sim, M. J., Malhotra, S., Palazzo, A. M., & Fuente, B. D. L. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70118-3 · Cited by 67
GRIFFITH, M. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.18.5460 · Cited by 65
Acylated non-α-amino acids as novel agents for the oral delivery of heparin sodium, USP
Leone‐Bay, A., Paton, D. R., Variano, B., Leipold, H., Rivera, T., Miura-Fraboni, J., Baughman, R. A., & Santiago, N. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00101-6 · Cited by 64
The effect of anticoagulants on cancer risk and survival: Systematic review
Tagalakis, V., Blostein, M. D., Robinson‐Cohen, C., & Kahn, S. R. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.02.004 · Cited by 61
Stevenson, K. J., Easton, A. C., Curry, A., THOMSON, J. M., & Poller, L. (1986) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661531 · Cited by 60
Cutaneous necrosis caused by systemically administered heparin.
Kelly, R. A., Gelfand, J. A., & Pincus, S. H. (1981) · PubMed · Cited by 58
Friedman, Y., & Arsenis, C. (1974) · Biochemical Journal · doi:10.1042/bj1390699 · Cited by 55
Sciumbata, T., Caretto, P., Pirovano, P., Pozzi, P., Cremonesi, P., Galimberti, G., Leoni, F., & Marcucci, F. (1996) · PubMed · Cited by 55
Mungall, D. R., Anbe, D. T., Forrester, P. L., Luoma, T., Genovese, R., Mahan, J., Leblanc, S., & Penney, J. B. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.73 · Cited by 54
Low molecular weight heparins: are they interchangeable? No
Nenci, G. G. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00017.x · Cited by 53
Ockelford, P., Carter, C. J., Cerskus, A. L., Smith, C. A., & Hirsh, J. (1982) · Thrombosis Research · doi:10.1016/0049-3848(82)90006-8 · Cited by 51
Self-citationHeparin Treatment of Deep Vein Thrombosis
Fagher, B., & Lundh, B. (1981) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1981.tb09831.x · Cited by 49
Racanelli, A., Fareed, J., Walenga, J. M., & Coyne, E. (1985) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1004373 · Cited by 47
The effects of phospholipid and factor Va on the inhibition of Factor Xa by antithrombin III
Walker, F. J., & Esmon, C. T. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91283-x · Cited by 44
In Vitro Reversal of Heparin Effect with Heparinas
Despotis, G. J., Summerfield, A. L., Joist, J. H., et al. (1994) · Anesthesia & Analgesia · doi:10.1213/00000539-199410000-00009 · Cited by 42
Heparin Metabolism: Isolation and Characterization of Uroheparin
McAllister, B. M., & Demis, D. J. (1966) · Nature · doi:10.1038/212293a0 · Cited by 40
Siè, P., Petitou, M., Lormeau, J. C., Dupouy, D., Boneu, B., & Choay, J. (1988) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(88)90111-0 · Cited by 40
An evaluation of empiric vs. nomogram-based dosing of heparin in an intensive care unit
Brown, G. R., & Dodek, P. (1997) · Critical Care Medicine · doi:10.1097/00003246-199709000-00021 · Cited by 40
Activation of heparin cofactor II by heparin oligosaccharides
Maimone, M. M., & Tollefsen, D. M. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80391-7 · Cited by 38
For the Initial Treatment of Venous Thromboembolism
van der Heijden, J. F., Prins, M. H., & Buller, H. R. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00272-3 · Cited by 38
Goldberg, S., Savage, M., & Fischman, D. L. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91083-2 · Cited by 36
Becker, R. C., Cannon, C. P., Tracy, R. P., Thompson, B., Bovill, E. G., Desvigne-Nickens, P. M., Randall, A. M. Y., Knatternud, G., & D, E. B. M. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90519-0 · Cited by 36
Antithrombin binding of low molecular weight heparins and inhibition of factor Xa
Lin, P. (2001) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(01)00117-9 · Cited by 36
Petitou, M., Lormeau, J. C., Perly, B., Berthault, P., Bossennec, V., Siè, P., & Choay, J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68359-0 · Cited by 35
Treatment of Venous Thromboembolism
Bates, S. M., & Hirsh, J. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615925 · Cited by 35
Self-citationVasoflux, a New Anticoagulant With a Novel Mechanism of Action
Weitz, J. I., Young, E., Johnston, M., Stafford, A. R., Fredenburgh, J. C., & Hirsh, J. (1999) · Circulation · doi:10.1161/01.cir.99.5.682 · Cited by 34
Self-citationIncomplete Reversal of Enoxaparin-Induced Bleeding by Protamine Sulfate
Bang, C. J., Berstad, A., & Talstad, I. (2009) · Haemostasis · doi:10.1159/000216220 · Cited by 33
Low molecular weight heparins: are they interchangeable? Yes
Prandoni, P. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00014.x · Cited by 28
Mechanisms for Inhibition of the Generation of Thrombin Activity by Sulfated Polysaccharidesa
Ofosu, F. A., Modi, G. J., Hirsh, J., Buchanan, M. R., & Blajchman, M. A. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb34566.x · Cited by 28
Self-citationManzato, F., Mengoni, A., Grilenzoni, A., & Lippi, G. (1998) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1998.168 · Cited by 27
Comparing Different Lots of Activated Partial Thromboplastin Time Reagent: Analysis of Two Methods
Rosborough, T. K. (1998) · American Journal of Clinical Pathology · doi:10.1093/ajcp/110.2.173 · Cited by 27
Nishioka, J., & Goodin, S. (2007) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155207079169 · Cited by 26
Overview of the Management of Thrombotic Disorders
Gallus, A. S. (1989) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002692 · Cited by 24
Hull, R. D. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0500 · Cited by 24
A Collaborative Study Designed to Establish the 4th International Standard for Heparin
Thomas, D. P., Curtis, A. D. M., & Barrowcliffe, T. W. (1984) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661160 · Cited by 24
Reilly, B. M., Raschke, R. A., Srinivas, S., & Nieman, T. (1993) · Journal of General Internal Medicine · doi:10.1007/bf02599634 · Cited by 23
Self-citation2 Mechanisms of action of low molecular weight heparins and heparinoids
Ofosu, F. A., & Barrowcliffe, T. W. (1990) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80016-2 · Cited by 20
Management of Iliofemoral Thrombosis in a Pregnant Patient With Heparin Resistance
Anand, S. S. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440280157015 · Cited by 15
Anticoagulant Activities of Heparin and Fragments
Barrowcliffe, T. W., & THOMAS, D. P. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb22497.x · Cited by 14
The Role of Low-Molecular-Weight Heparins in Arterial Diseases
Cohen, M. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00273-5 · Cited by 13
A novel protamine variant reversal of heparin anticoagulation in human blood in vitro
Hulin, M. S., Wakefield, T. W., Andrews, P., Wrobleski, S. K., Stoneham, M. D., Doyle, A. R., Zelenock, G. B., Jacobs, L. A., Shanley, C. J., TenCate, V. M., et al. (1997) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(97)70018-1 · Cited by 13
The Use of a Heparin Removal Device: A Valid Alternative to Protamine
Hendrikx, M., Leunens, V., Vandezande, E., Wallyn, A., & Flameng, W. (1997) · The International Journal of Artificial Organs · doi:10.1177/039139889702000308 · Cited by 9
Cited by
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,487
Prevention of Venous Thromboembolism
Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · Chest · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,373
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.181940 · Cited by 1,853
Hirsh, J., Warkentin, T. E., Shaughnessy, S. G., Anand, S. S., Halperin, J. L., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (2001) · Chest · doi:10.1378/chest.119.1_suppl.64s · Cited by 1,580
Self-citation
Metadata
- Authors
- Hirsh, J., Warkentin, T. E., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 1998-11
- Volume
- 114
- Issue
- 5
- Pages
- 489S-510S
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2063207586
- Cited by
- 1,031
- References
- 280
- FWCI
- 35.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.